Antagonism of the apomorphine-induced yawning by "atypical" neuroleptics
- PMID: 6129594
- DOI: 10.1016/0028-3908(82)90181-2
Antagonism of the apomorphine-induced yawning by "atypical" neuroleptics
Abstract
In relatively small doses, the four "atypical" neuroleptics, sulpiride, clozapine, thoiridazine and mezilamine were effective antagonists of apomorphine-induced yawning in rats. Of the four drugs, used in doses which inhibited apomorphine-induced yawning almost completely, only clozapine also antagonized yawning induced by physostigmine. Therefore it appears that the antagonism of this effect of apomorphine, already reported for classical neuroleptic agents, is also shown by "atypical" ones. By combining apomorphine- and physostigmine-induced yawning, it is possible to assess the anticholinergic component in the antagonism of this effect of apomorphine and this may be of value for the understanding of the mechanisms underlying the "atypical" character.
Similar articles
-
Atypical neuroleptics suppress dopaminergic behavioral supersensitivity.Psychopharmacology (Berl). 1990;100(3):399-403. doi: 10.1007/BF02244614. Psychopharmacology (Berl). 1990. PMID: 1969173
-
Modification of apomorphine-, physostigmine- and pilocarpine-induced yawning after long-term treatment with neuroleptic or cholinergic agents.Arch Int Pharmacodyn Ther. 1984 Oct;271(2):180-8. Arch Int Pharmacodyn Ther. 1984. PMID: 6150689
-
Pharmacological characteristics of dopamine receptors involved in the dual effect of dopamine agonists on yawning behaviour in rats.Eur J Pharmacol. 1983 Oct 28;94(3-4):271-80. doi: 10.1016/0014-2999(83)90416-8. Eur J Pharmacol. 1983. PMID: 6140175
-
Biochemical and behavioural properties of clozapine.Psychopharmacology (Berl). 1989;99 Suppl:S6-12. doi: 10.1007/BF00442552. Psychopharmacology (Berl). 1989. PMID: 2573106 Review.
-
Clozapine: an atypical neuroleptic.Neurosci Biobehav Rev. 1990 Winter;14(4):357-63. doi: 10.1016/s0149-7634(05)80058-2. Neurosci Biobehav Rev. 1990. PMID: 2287476 Review.
Cited by
-
Dopamine agonist-induced yawning in rats: a dopamine D3 receptor-mediated behavior.J Pharmacol Exp Ther. 2005 Jul;314(1):310-9. doi: 10.1124/jpet.105.085472. Epub 2005 Apr 15. J Pharmacol Exp Ther. 2005. PMID: 15833897 Free PMC article.
-
Interactions of drugs acting on central dopamine receptors and cholinoceptors on yawning responses in the rat induced by apomorphine, bromocriptine or physostigmine.Br J Pharmacol. 1989 Apr;96(4):843-8. doi: 10.1111/j.1476-5381.1989.tb11893.x. Br J Pharmacol. 1989. PMID: 2663110 Free PMC article.
-
Multifocal sites of action involved in dopaminergic-cholinergic neuronal interactions in yawning.Psychopharmacology (Berl). 1988;95(1):34-7. doi: 10.1007/BF00212762. Psychopharmacology (Berl). 1988. PMID: 3133698
-
Yawning is elicited by D2 dopamine agonists but is blocked by the D1 antagonist, SCH 23390.Psychopharmacology (Berl). 1987;91(3):330-3. doi: 10.1007/BF00518186. Psychopharmacology (Berl). 1987. PMID: 2882540
-
Psychotic Symptoms Associated with the use of Dopaminergic Drugs, in Patients with Cocaine Dependence or Abuse.Curr Neuropharmacol. 2017;15(2):315-323. doi: 10.2174/1570159x14666160324144912. Curr Neuropharmacol. 2017. PMID: 27009114 Free PMC article. Review.